Prot #GALACTIC-1: A Randomized, Double-blind, Multicentre, Parallel, Placebo-controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a

  • Tomic, Rade (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/23/2010/29/25

Funding

  • INC Research, LLC ((OE) Prot #GALACTIC-1 // (OE) Prot #GALACTIC-1)
  • Galecto Biotech ApS ((OE) Prot #GALACTIC-1 // (OE) Prot #GALACTIC-1)